Oral GLP-1 medications as good as injections!?

The new semaglutide 25 mg pill, studied in the OASIS-4 clinical trial, helped participants lose an average of 13–16 % of their body weight over one year. For many, it may offer the same powerful results as injectable GLP-1 medications — but in a once-daily oral form.